After SREBP2 knockout in tumor cells or simvastatin treatment, we observed that these interventions significantly promoted NK cell‐mediated cytotoxicity against gastric cancer in vivo and prolonged the survival of tumor‐bearing mice (Fig. 6A,B). The gene discussed is SREBF2; the disease is neoplasm.